| P2093 | author name string | Steven D Hollon | |
| | Ellen Driessen | |
| P2860 | cites work | Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials | Q22251387 |
| | The empirical status of cognitive-behavioral therapy: A review of meta-analyses | Q22252278 |
| | Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression | Q24647719 |
| | Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression | Q28255241 |
| | A component analysis of cognitive-behavioral treatment for depression | Q28293596 |
| | National Institute of Mental Health Treatment of Depression Collaborative Research Program | Q29302645 |
| | The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) | Q29547223 |
| | Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study | Q29615116 |
| | Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression | Q33605850 |
| | Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial | Q33860963 |
| | Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial | Q34195690 |
| | Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects | Q34294144 |
| | Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program | Q34298476 |
| | Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design | Q34310720 |
| | Cognitive therapy vs medications in the treatment of moderate to severe depression | Q34408868 |
| | A meta-analysis of the effects of cognitive therapy in depressed patients | Q34466938 |
| | Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety | Q34471476 |
| | A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year | Q34531152 |
| | Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. | Q34551633 |
| | Prevention of relapse following cognitive therapy vs medications in moderate to severe depression | Q34556472 |
| | Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program | Q34785429 |
| | Cognitive therapy of depression: pretreatment patient predictors of outcome | Q34818698 |
| | Mediators and moderators of treatment effects in randomized clinical trials | Q34940844 |
| | Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? | Q36091761 |
| | Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program | Q36630487 |
| | Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects | Q37070494 |
| | Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder | Q37193416 |
| | Does psychotherapy homework lead to improvements in depression in cognitive-behavioral therapy or does improvement lead to increased homework compliance? | Q40774668 |
| | Prospects for future comparisons between drugs and psychotherapy: lessons from the CBT-versus-pharmacotherapy exchange | Q40950447 |
| | Preventing hung juries about therapy studies | Q40950452 |
| | Cognitive-behavior therapy versus pharmacotherapy: Now that the jury's returned its verdict, it's time to present the rest of the evidence | Q41201789 |
| | Long-term treatment of recurrent and chronic depression. | Q43776747 |
| | Is cognitive-behavioural therapy more effective than psychoeducation in bipolar disorder? | Q43828990 |
| | Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: a preliminary report | Q43960860 |
| | Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder | Q44156707 |
| | Validity of sudden gains in acute phase treatment of depression | Q45264195 |
| | Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination. | Q46133966 |
| | A randomized controlled trial of cognitive therapy for bipolar disorder: focus on long-term change. | Q47340715 |
| | How does cognitive therapy work? Cognitive change and symptom change in cognitive therapy and pharmacotherapy for depression | Q47354672 |
| | Cognitive reactivity to sad mood provocation and the prediction of depressive relapse. | Q50932443 |
| | Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. | Q51125538 |
| | The process of change in cognitive therapy and pharmacotherapy for depression. Changes in mood and cognition. | Q51236327 |
| | Extreme nonresponse in cognitive therapy: can behavioral activation succeed where cognitive therapy fails? | Q51901050 |
| | Attachment as moderator of treatment outcome in major depression: a randomized control trial of interpersonal psychotherapy versus cognitive behavior therapy. | Q51909188 |
| | Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. | Q51919569 |
| | Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial. | Q51930956 |
| | Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression. | Q51938393 |
| | Treatment and Prevention of Depression. | Q52009697 |
| | Impact of Cluster C personality disorders on outcomes of contrasting brief psychotherapies for depression. | Q52012142 |
| | The role of avoidance and obsessiveness in matching patients to cognitive and interpersonal psychotherapy: empirical findings from the treatment for depression collaborative research program. | Q52199602 |
| | Therapeutic empathy and recovery from depression in cognitive-behavioral therapy: A structural equation model | Q52420354 |
| | A meta-(re)analysis of the effects of cognitive therapy versus 'other therapies' for depression. | Q54070942 |
| | A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. | Q55033901 |
| | Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. | Q55051636 |
| | Sudden Gains in Cognitive Therapy for Depression: A Replication and Extension | Q57310093 |
| | Patients' competence in and performance of cognitive therapy skills: Relation to the reduction of relapse risk following treatment for depression | Q57335464 |
| | Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression | Q57335469 |
| | Sudden gains in cognitive therapy of depression and depression relapse/recurrence | Q57335473 |
| | The Relation of Patients’ Treatment Preferences to Outcome in a Randomized Clinical Trial | Q57335476 |
| | Cognitive Changes, Critical Sessions, and Sudden Gains in Cognitive-Behavioral Therapy for Depression | Q57335490 |
| | Sudden gains and critical sessions in cognitive-behavioral therapy for depression | Q57335546 |
| | The temporal relation of adherence and alliance to symptom change in cognitive therapy for depression | Q57335552 |
| | Cognitive Therapy and Pharmacotherapy for Depression | Q57335601 |
| | Determinants of change in cognitive therapy for depression | Q57335633 |
| | Cognitive Therapy for Bipolar Illness—A Pilot Study of Relapse Prevention | Q58430030 |
| | Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy | Q59345546 |
| | Unlinking Negative Cognition and Symptoms of Depression: Evidence of a Specific Treatment Effect for Cognitive Therapy | Q60152949 |
| | Preventing Relapse/Recurrence in Recurrent Depression With Cognitive Therapy: A Randomized Controlled Trial | Q60447010 |
| | Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients | Q61480148 |
| | Mode-specific effects among three treatments for depression | Q68523737 |
| | Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program | Q68794507 |
| | Causal mediation of change in treatment for depression: discriminating between nonspecificity and noncausality | Q69165733 |
| | A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both | Q69993121 |
| | Coping styles, homework compliance, and the effectiveness of cognitive-behavioral therapy | Q70150893 |
| | Severity of depression and response to cognitive behavior therapy | Q70160675 |
| | The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination | Q71035035 |
| | The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program | Q71236813 |
| | Cognitive therapy and pharmacotherapy. Singly and together in the treatment of depression | Q71254993 |
| | Therapist competence ratings in relation to clinical outcome in cognitive therapy of depression | Q73269170 |
| | Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association | Q73682867 |
| | Prevention of relapse in residual depression by cognitive therapy: a controlled trial | Q73716943 |
| | Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression | Q73887182 |
| | Reducing relapse in depressed outpatients with atypical features: a pilot study | Q74242630 |
| | How does cognitive therapy prevent relapse in residual depression? Evidence from a controlled trial | Q74336567 |
| | Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings | Q77295286 |
| | Temperament, character and personality disorders as predictors of response to interpersonal psychotherapy and cognitive-behavioural therapy for depression | Q80412593 |
| | Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years | Q81333670 |
| | What can we conclude from studies on psychotherapy in bipolar disorder? Invited commentary on...Cognitive-behavioural therapy for severe and recurrent bipolar disorders | Q83043635 |
| | Predicting the effect of cognitive therapy for depression: a study of unique and common factors | Q95819801 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mood disorder | Q188638 |
| | cognitive behavioral therapy | Q1147152 |
| P304 | page(s) | 537-55 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | Psychiatric Clinics of North America | Q7256223 |
| P1476 | title | Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators | |
| P478 | volume | 33 | |